Cyclo Therapeutics, Inc.·4

Aug 30, 7:02 PM ET

FINE N SCOTT 4

4 · Cyclo Therapeutics, Inc. · Filed Aug 30, 2021

Insider Transaction Report

Form 4
Period: 2021-08-27
FINE N SCOTT
Director
Transactions
  • Award

    Stock Option (Right to buy)

    2021-08-27+57,30057,300 total
    Exercise: $7.46Exp: 2031-08-27Common Stock (57,300 underlying)
Footnotes (1)
  • [F1]The option vests over a four year period in equal monthly installments.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4